move to main move to category
The SBI Group's New Challenges as Ever-evolving

News Release

Mar 26
Notice Regarding Conversion of Zero Coupon Convertible Bonds due 2025
Mar 22
Notice Regarding Investment in Sturgeon Emerging Opportunities II, a Startup Investment Fund Targeting Central Asian Region with Focus on Uzbekistan
Mar 21
Notice Regarding Investment in Solaris SE, which Provides Banking Functions to Partner Companies in Europe Through Embedded Finance
Feb 29
Notice of Exercise of Call Option on the Zero Coupon Convertible Bonds due 2025
Feb 7
Notice Regarding Revision to Dividend Forecast and Implementation of the 25th Anniversary Commemorative Dividend
Jan 31
SBI Pharmaceuticals and TAGCyx ANNOUNCES A MILESTONE ACHIEVEMENT OF THE RESEARCH AND DEVELOPMENT COLLABORATION OF INNOVATIVE CANCER THERAPY

Information

Feb 7
[Audio Streaming (Briefing of SBI Holdings Financial Results) and English presentation material] SBI Holdings, Inc. Financial Results for the Nine-month Period Ended December 31, 2023 (Fiscal Year Ending March 31, 2024) was updated.
Feb 7
Financial Results was updated.
Dec 1
[English presentation material] Presentation was updated.
Nov 10
[Audio Streaming (Briefing of SBI Holdings Financial Results) and English presentation material] SBI Holdings, Inc. Financial Results for the six-month Period Ended September 30, 2023 (Fiscal Year Ending March 31, 2024) was updated.
Nov 10
IR Calendar was updated.